baber/WOPTO huggingface dataset:
Patent NZ-571097-A (NZ)
Title: Method and apparatus for stabilising strip during winding
Inventor: BATEMAN IAN ROGER
IPC: B29C53/80
Filed: 2007-03-08
Abstract: A spool winding assembly for winding a composite strip onto a spool having a hub is disclosed. The strip (10) it winds includes: an elongate plastic strip having a flat base portion and a plurality of laterally spaced apart lengthwise extending rib portions upstanding from the base portion on one surface of the plastic strip; and a plurality of elongate reinforcing members extending lengthwise within respective rib portions, the rib portions and the reinforcing members forming composite ribs. The spool winding assembly includes: a main frame (202); a spool holder (204) for rotatably supporting the spool relative to the main frame; a spool drive unit (206) for driving the spool with respect to the main frame; a carriage (240) mounted for lateral movement with respect to the spool; a bender (90) mounted to the carriage (240) configured to receive the composite strip (10) as the composite strip (10) is fed towards the hub (55) of the spool during use and configured to deform the composite strip (10) to give the composite strip a curved base portion; and a bender drive unit (210) operably connected to the bender (90) for driving the strip through the bender. The bender (90) comprises: a bender frame, a pair of parallel spaced apart support rollers, a set rollers parallel to the support rollers. The pair of parallel spaced apart support rollers are rotatably mounted to the bender frame. At least one of the support rollers defines a surface configured to contact the flat base portion from which the composite ribs extend, and further define grooves configured to receive the composite ribs of the composite strip while the flat base portion contacts the surface of the support roller. The set rollers parallel to the support rollers are rotatably mounted to the bender frame and arranged to roll on a side of the base portion opposite the surface from which the composite ribs extend. The set roller is positioned such that as the composite strip is driven between the support rollers and the set roller, the composite strip is deformed such that the composite strip exits the bender with a curved base portion.
Patent NZ-581085-A (NZ)
Title: A frost fan having a tower that has a reduced diameter in the vicinity of the blast from the fan
Inventor: KARN RICHARD
IPC: A01G13/08
Filed: 2009-11-11
Abstract: A wind machine, or frost fan, operating as a pedestal fan, blowing air into a crop during frosty weather, is disclosed. The fan has a tower that has a substantially reduced diameter, of at least 50%, in the vicinity of the blast from the fan.
Patent NZ-585139-A (NZ)
Title: 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as jak inhibitors
Inventor: LI YUN-LONG
IPC: A61P35/00
Filed: 2008-11-13
Abstract: Disclosed is a compound of Formula IIa, IIb, IIc, IId, IIe, IIf, or IIg e.g. 3-(cyanomethyl)-3-[4-(2-{ [3-(2-oxopyrrolidin-1-yl)phenyl]amino} pyrimidin-4-yl)-1H-pyrazol-1-yl]cyclobutanecarbonitrile, or pharmaceutically acceptable salt thereof, wherein Ring A is aryl or heteroaryl and the other the substitiuents are defined in the specification for treating rheumatoid arthritis, psoriasis and polycythemia vera (PV), essential thrombocythemia (ET), myeloid metaplasia with myelofibrosis (MMM), chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia (CMML), hypereosinophilic syndrome (HES), idiopathic myelofibrosis (IMF), or systemic mast cell disease (SMCD).
Patent NZ-588500-A (NZ)
Title: Use of L. plantarum DSM 2648 to treat gastrointestinal barrier conditions
Inventor: ANDERSON RACHEL
IPC: A23L29/00
Filed: 2008-05-16
Abstract: Provided is a composition which includes Lactobacillus plantarum DSM 2648 together with a non-fermented and/or non-milk based animal feed or animal drink. The composition can be used to prevent, alleviate and/or treat a disease, an ailment, or disorder associated with the gastrointestinal barrier together with a non-fermented and/or non-milk based animal feed or animal drink. The dosage of L. plantarum DSM2648 to an animal or group of animals can be administered by applying a liquid formulation, which includes L.plantarum DSM2648 as an active ingredient, to a pasture or animal feed.
Patent NZ-588674-A (NZ)
Title: Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
Inventor: MASTERNAK KRZYSZTOF
IPC: C07K16/24
Filed: 2009-05-05
Abstract: Disclosed are fully human monoclonal antibodies that recognize IL- 17F, the IL- 17F homodimer, IL- 17A, the IL- 17A homodimer, and/or the heterodimeric IL- 17A/IL-17F protein complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Patent NZ-590068-A (NZ)
Title: Adamantyl diamide derivatives and uses of same
Inventor: JIMENEZ HERMOGENES N
IPC: A61K31/4412
Filed: 2009-07-17
Abstract: The disclosure relates to adamantyl-diamide derivatives of formula (I): wherein the variables R1 and R2 are as defined in the specification, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same. These compounds are suitable for the treatment of central nervous system disease or disorder selected from a cognitive, neurodegenerative, psychiatric or neurological disease or disorder, wherein the cognitive or neurodegenerative disease or disorder is selected from a group consisting of a mood disorder, an anxiety, a schizophrenia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's neurodegeneration, AIDS-induced encephalopathy, a non-AIDS-induced encephalopathy, Fragile X syndrome, an autism spectrum disorder, and a combination thereof.
Patent NZ-595560-A (NZ)
Title: Valve comprising a housing with drive housing within, wherein the drive housing houses a motor which drives a closure element, the closure element being a rolling element screw
Inventor: ESVELDT VINCENT
IPC: F16K1/12
Filed: 2010-06-08
Abstract: A valve comprising a housing, which has an inlet opening for a fluid, a closure element, by means of which a flow of the fluid can be controlled, and an outlet opening for the fluid, and comprising an actuating device (8), which has an electrical actuating drive (17) for adjusting a closure cross-section of the closure element, and comprising a drive housing (15), to which a stator (16) of the actuating drive (17) is rigidly connected, wherein a moving rotor (19) of the actuating drive is kinematically coupled to the closure element in an interior (20) of the drive housing, the interior being under a pressure of the fluid, and the stator is arranged within the interior. In order to use a valve having an actuating drive lying in the fluid for fluids having abrasive and corrosive components, the interior of the drive housing is separated from the fluid by means of a moving separating element.
Patent NZ-595622-A (NZ)
Title: Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides
Inventor: LEMIEUX RENE MARC
IPC: A61K31/501
Filed: 2010-05-26
Abstract: 595622 Disclosed herein are derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease. In one embodiment the derivative is (R)-5-(4-cyano-benzyl)-7-(3,5-dichloro-4-fluoro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid ((1S,2R)-1-{ 1-[5-(1,3-dimethyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-cyclopropylcarbamoyl} -2-hydroxy-propyl)-amide.
Patent NZ-596581-A (NZ)
Title: A decanter centrifuge and a screw conveyor
Inventor: GRONNEGAARD ERLAND
IPC: B04B1/20
Filed: 2010-06-11
Abstract: 596581 Disclosed is a screw conveyor for use with, and a decanter centrifuge for separating a supplied material in a light phase and a heavy phase. The centrifuge comprises an elongate bowl arranged for rotation about its longitudinal axis, the bowl having a separation chamber with a circumferential wall, a screw conveyor (3) being provided in the separation chamber and being coaxial with the bowl, the screw conveyor comprising a conveyor hub (14). The conveyor hub comprises a longitudinal tubular steel body part (18) and a helical steel conveyor flight (15) attached to the tubular steel body part. The conveyor hub further comprises an inner longitudinal body extending coaxially relative the longitudinal tubular steel body part. The inner longitudinal body (19) is extending through at least a part of the tubular steel body and is made of a first material, such as carbon fibre reinforced epoxy, whose specific modulus is larger than specific modulus of the steel material of the tubular steel body part.
Patent NZ-598063-A (NZ)
Title: Gram-positive bacteria specific binding compounds
Inventor: BEAUMONT TIM
IPC: C12N15/13
Filed: 2010-07-15
Abstract: Disclosed is an isolated antibody comprising: a)a heavy chain CDR1 sequence RFAMS (SEQ ID NO:1); b)a heavy chain CDR2 sequence STNNGNNPYYARSVQY (SEQ ID NO:2) or SINSGNNPYYARSVQY (SEQ ID NO:60); c)a heavy chain CDR3 sequence DHPSSGWPTFDS (SEQ ID NO:3); d)a light chain CDR1 sequence RASENVGDWLA (SEQ ID NO:4); e)a light chain CDR2 sequence KTSILES (SEQ ID NO:5); and f)a light chain CDR3 sequence having at least 88% identity to QHYXRFPYT, wherein X is any amino acid. Also disclosed is the use of said antibody in the manufacture of a medicament for treating gram-positive bacterium related disorders.
Patent NZ-601724-A (NZ)
Title: Improvements in and relating to corrugated board and the manufacture thereof
Inventor: VAN BERLO PATRICK PETRUS ANTONIUS MARIA
IPC: B31D3/00
Filed: 2012-08-09
Abstract: A corrugated board which includes a sheet of corrugated material 101, and at least one planar sheet of material 100 bonded to at least one surface of the sheet of corrugated material. The corrugated sheet and planar sheet(s) include a plurality of perforations 106, 107 spread over at least a portion of the respective surfaces thereof which are substantially aligned to create passages through the corrugated board. The perforations 106, 107 are dimensioned to be substantially 0.5mm2 - 2.00mm2 in size and spaced at least substantially 4mm - 10 mm apart from one another.
Patent NZ-602921-A (NZ)
Title: Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
Inventor: KLEIN THOMAS
IPC: A61P3/10
Filed: 2011-05-05
Abstract: The present disclosure relates to methods for maintaining a reduced body weight and/or body fat after initial weight reducing treatment or for attenuating or preventing or treating rebound of weight and/or fat gain following discontinuation of treatment with a GLP-1 receptor agonist. The methods comprises the administration of lignagliptin following weight loss treatment. The conditions may be type 2 diabetes, obesity or both. The GLP-1 receptor agonist can selected from exenatide, exenatide LAR, liraglutide, taspoglutide, semaglutide, albiglutide, lixisenatide and dulaglutide. The weight loss treatment is administered to a overweight or obese patient with or without diabetes, particularly in a type 2 diabetes patient being obese or overweight.
Patent NZ-603874-A (NZ)
Title: Oral dosage forms of bendamustine and therapeutic use thereof
Inventor: OUATAS TAOUFIK
IPC: A61K9/14
Filed: 2011-06-01
Abstract: In the present disclosure there is provided a pharmaceutical composition for oral administration which comprises bendamustine or a pharmaceutically acceptable, ester, salt or solvate thereof as an active ingredient, and a pharmaceutically acceptable excipient and which shows a dissolution of the bendamustine of at least 60% in 20 minutes, 70% in 40 minutes and 80% in 60 minutes, as measured with a paddle apparatus at 50 rpm according to the European Pharmacopoeia in 500 ml of a dissolution medium at a pH of 1.5, and wherein the pharmaceutically acceptable excipient is either a pharmaceutically acceptable non-ionic surfactant, selected from the group consisting of a polyethoxylated castor oil or derivative thereof and a block copolymer of ethylene oxide and propylene oxide or a pharmaceutically acceptable saccharide selected from the group consisting of one or more of a monosaccharide, a disaccharide, an oligosaccharide, a cyclic oligosaccharide, a polysaccharide and a saccharide alcohol, wherein the ratio by weight of the active ingredient to the saccharide excipient(s) is in the range of 1:1-5. The disclosure further relates to the above pharmaceutical composition for use for the oral treatment of a medical condition which is selected from chronic lymphocytic leukemia, acute lymphocytic leukaemia, chronic myelocytic leukaemia, acute myelocytic leukaemia, Hodgkin’s disease, non-Hodgkin’s lymphoma, multiple myeloma, breast cancer, ovarian cancer, small cell lung cancer and non-small cell lung cancer. The disclosure moreover relates to the above pharmaceutical composition for the above use wherein the dosage regimen comprises at least the administration of a dose of 100 to 600 mg/m2/per person of bendamustine on day 1 and day 2, optionally a dose of 50 to 150 mg/m2 i.v. or orally of a corticosteroid on days 1 to 5, and optionally a suitable dose of a further active agent selected from the group consisting of an antibody specific for CD20, an anthracyclin derivative, a vinca alkaloid or a platin derivative; and the repetition of said dosage regimen 4 to 15 times after intervals of two to four weeks.
Patent NZ-606124-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: G01N33/53
Filed: 2011-06-23
Abstract: Disclosed is a method for evaluating renal status in a subject ex vivo, comprising: -performing one or more assays configured to detect C-X-C Motif chemokine 13 in a body fluid sample obtained previously from the subject; -determining an assay result(s) comprising a measured level of the C-X-C Motif chemokine 13; and -correlating an assay result( s) to the renal status of the subject said correlating comprising comparing a measured concentration of the C-X-C Motif chemokine 13 to a threshold concentration of C-X -C Motif chemokine 13 and assigning a likelihood or non-likelihood of an event occurring or having occurred when the measured concentration varies from the threshold.
Patent NZ-616672-A (NZ)
Title: Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
Inventor: LANDER CYNTHIA
IPC: C07K7/08
Filed: 2012-04-12
Abstract: Disclosed is the use of (a) a polypeptide of the amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or a functional equivalent thereof selected from the group consisting of -a polypeptide of amino acid sequence FAKLAARLYRKALARQLGVAA (SEQ ID NO: 3); -a polypeptide of amino acid sequence KAFAKLAARLYRKALARQLGVAA (SEQ ID NO: 4); -a polypeptide of amino acid sequence YARAAARQARAKALARQLAVA (SEQ ID NO: 5); -a polypeptide of amino acid sequence YARAAARQARAKALARQLGVA (SEQ ID NO: 6); and -a polypeptide of amino acid sequence HRRIKAWLKKIKALARQLGVAA (SEQ ID NO: 7); and (b) a pharmaceutically acceptable carrier in the manufacture of a medicament for therapeutic treatment of an injury to lung tissue progressing to loss of lung function, the lung injury comprising one or more of an aberrant deposition of an extracellular matrix protein in a pulmonary interstitium, wherein the extracellular matrix protein is collagen, an aberrant promotion of fibroblast proliferation in the lung, an aberrant induction of myofibroblast differentiation in the lung, and/or an aberrant promotion of attachment of myofibroblasts to an extracellular matrix compared to a normal healthy control subject, wherein the medicament is formulated for delivery to lung tissue of a subject by inhalation.
Patent NZ-617952-A (NZ)
Title: Improvements in solvent recovery
Inventor: MAYNARD NIGEL PAUL
IPC: H05B6/64
Filed: 2009-04-27
Abstract: Disclosed is a method of improving the RF/microwave recovery of organic substrate treatment solvent from an organic substrate (particularly dry lumber), the method including the steps of; (i) treating the organic substrate with a composition including: a) an organic substance treatment compound (e.g. azole compounds (like tebuconazole etc.), sub-micron copper, or alternatively any compound such as a resin, a polymer, monomer/pre-polymeric material that can alter the physical properties of the substrate), b) an organic substance treatment solvent (such as Stoddard solvent, chlorinated hydrocarbon solvents, low molecular weight hydrocarbon solvents, oils, aromatic hydrocarbon solvents, low polarity ether or ketone solvents including acetone etc.), and c) a dielectric loss enhancing additive (preferably selected from a highly polar organic solvent selected from water, N-methylpyrrolidone, dimethylsulphoxide, dimethylformamide, ethanol, 1-propanol, ethylene glycol etc.); and (ii) recovering the solvent using RF (microwave) energy at any suitable frequency.
Patent NZ-619944-A (NZ)
Title: Systems, apparatus, and methods for collaborative and distributed emergency multimedia data management
Inventor: ESTRADA LORENZO JAVIER
IPC: H04W4/90
Filed: 2012-06-18
Abstract: Disclosed is a system for collaborative and distributed emergency multimedia data management. The system includes a packet data reception interface configured to receive first emergency event packet data and second emergency event packet data. The first emergency event packet data is received at a first time prior to a second time when the second emergency event packet data is received. The system also includes a rules engine coupled with the packet data reception interface. The rules engine is configured to select a processing profile for the second emergency event packet data using a value included in the second emergency event packet data, the processing profile identifying an event routing plan for the second emergency event packet data. The event routing plan identifies a networked application to receive the second emergency event packet data. The rules engine is also configured to associate the second emergency event packet data with the first emergency event packet data based on proximity of a first item or a first location identified in the first emergency event packet data to a second time or a second location identified in second emergency event packet data. The system also includes a policy engine coupled with the rules engine and configured to execute the processing profile for the second emergency event packet data.
Patent NZ-620865-A (NZ)
Title: Parenteral norovirus vaccine formulations
Inventor: RICHARDSON CHARLES
IPC: A61K39/125
Filed: 2012-07-11
Abstract: Disclosed is the use of a vaccine composition comprising genogroup I or genogroup II Norovirus virus-like particles (VLPs) in the manufacture of a medicament for eliciting protective immunity against Norovirus in a human, wherein said genogroup I or genogroup II Norovirus VLPs comprise a capsid protein derived from a genogroup I or genogroup II viral strain, and wherein the medicament is formulated for: (a) administration of no more than a single dose of the vaccine composition; (b) administration parenterally; and (c) inducing at least a three-fold increase in Norovirus-specific serum antibody titer as compared to the titer in the human prior to administration of the medicament.
Patent NZ-703168-A (NZ)
Title: Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
Inventor: LABRIE FERNAND
IPC: A61P15/12
Filed: 2013-07-19
Abstract: The present invention relates to the use of DHEA (5-dehydroepiandrosterone, as pictured) in the manufacture of an intravaginal medicine for the treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder and female sexual interest arousal disorder in a woman who either (1) is not suffering from symptoms of vulvo-vaginal atrophy and/or (2) is not suffering from moderate to severe dyspareunia.
Patent NZ-706366-A (NZ)
Title: An inhaler
Inventor: HEARN ALEX
IPC: A24F42/60
Filed: 2013-08-27
Abstract: An inhaler comprising a reservoir (2) of an inhalable composition, A valve element (11) moved by a flexible diaphragm (14) and biased into a position in which it closes a composition flow path from a reservoir. A first air flow path (16) is partly defined by one side of the diaphragm and a second air flow path (17) is partly defined by the opposite side of the diaphragm. Each flow path has an outlet (19f 21) opening at an outlet end and the second flow path has an inlet (20) upstream of the outlet end. The air flow paths (16, 17) are arranged such that suction at the outlet end causes a reduction in pressure in the first air flow path relative to the pressure in the second air flow path creating a pressure differential across the diaphragm (14) that moves the valve element (11) against the biasing force to open the composition flow path.
Patent NZ-706930-A (NZ)
Title: Genetic markers for myb28
Inventor: MITHEN RICHARD F
IPC: C12N5/04
Filed: 2013-09-04
Abstract: Disclosed is a primer or probe that amplifies and/or hybridizes to at least one polymorphism at a position corresponding to nucleotide 1116 of SEQ ID NO:1. Further disclosed is a primer pair comprising primers of the sequences of SEQ ID NO: 6 and SEQ ID NO: 12 and that amplifies at least one polymorphism at a position corresponding to nucleotide 1116 of SEQ ID NO:1.
Patent NZ-708156-A (NZ)
Title: Amine and amine oxide surfactants for controlling herbicide spray drift
Inventor: LIU LEI
IPC: A01N57/20
Filed: 2011-09-14
Abstract: Disclosed herein are aqueous concentrate compositions comprising from about 5 to about 40% by weight of a water soluble salt of glyphosate, and from about 5 to about 40% by weight of a water soluble salt of at least one auxinic herbicide such as triclopyr, 2,4-D and dicamba, and from about 1 to about 20% by weight of a tertiary amine surfactant. Also disclosed are methods for reducing spray drift during the application of an aqueous herbicide composition containing glyphosate and an auxinic herbicide comprising incorporating into the mixture from about 0.02 to 2% by weight of a tertiary amine surfactant.